LIOS and TBD Pharmatech join forces
On 21st February 2023, the Latvian Institute of Organic Synthesis (LIOS) and TBD Pharmatech signed the Memorandum of Understanding to strengthen the drug manufacturing performance of the Baltic region….
Read moreResources
-
MäRTS 2, 2023
-
-
VEEBRUAR 28, 2023
Pharmaceutical compliance
Pharmaceutical compliance is a crucial part of the drug development process. It includes the processes and activities undertaken by a pharmaceutical company to ensure that its products meet all the…
Read more-
-
VEEBRUAR 10, 2023
Maarjavälja career day 2023
On 9th of February the annual Maarjavälja career day 2023 took place. The career day is organized by Faculty of Science and Technology of University of Tartu. The event brings together companies and…
Read more-
-
JAANUAR 26, 2023
Medicine shortage: actions taken in Estonia and EU
Lately the shortage of medicines and health products has become an important topic everywhere around the world. Health professionals from European countries, as well as from Canada and US have been…
Read more-
-
JAANUAR 24, 2023
CMC in pharma
Chemistry, Manufacturing and Controls (CMC) is a critical component of the drug development process. CMC in pharma is responsible for ensuring that the drugs being developed are safe, effective and…
Read more-
-
JAANUAR 16, 2023
Change of legal name – officially TBD Pharmatech
On Friday, 13th of January 2023 the legal name of our company was changed to osaühing TBD Pharmatech. We started using the new name already in September 2022 as it was a big part of the whole rebranding…
Read more-
Ravimainete arendaja ja tootja, mis pakub peenkeemia lahendusi farmaatsia- ja biotehnoloogia ettevõttetele.